Brief: Radiopharm Theranostics Initiates Process For Nasdaq Listing
13/02/2023 23:30
Feb 14 (Reuters) - Radiopharm Theranostics Ltd RAD.AX :
* INITIATES PROCESS FOR NASDAQ LISTING
* FILED REGISTRATION STATEMENT WITH US SECURITIES AND
EXCHANGE
COMMISSION AND LISTING APPLICATION WITH NASDAQ
Source text for Eikon: ID:nASX1hCQ5D
Further company coverage: RAD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%